← The Wire
AGIONasdaq
AGIOS PHARMACEUTICALS, INC.
Pharmaceutical Preparations · DE · CIK 1439222
Biopharmaceutical company developing and delivering innovative medicines for rare diseases
red 8-K · 90d
$1.75B
Market cap
$38.04
Last close
+0.4%
1D
+8.4%
5D
772K
Volume
Price · last 39 sessions+38.0%
May 4L $26.51 · H $38.04Jun 29
252
Total filings
Jun 18, 2026
Last filing
12/31
Fiscal year end
8-KExecutive Change · Shareholder VoteJun 18, 202610-Q10-QApr 29, 20268-KResults of OperationsApr 29, 2026DEFA14ADEFA14AApr 24, 2026DEF 14ADEF 14AApr 24, 202610-K10-KFeb 12, 20268-KResults of OperationsFeb 12, 20268-KReg FD DisclosureJan 12, 202610-Q10-QOct 30, 20258-KResults of OperationsOct 30, 20258-KReg FD DisclosureAug 4, 202510-Q10-QJul 31, 20258-KResults of OperationsJul 31, 20258-KExecutive ChangeJul 8, 20258-KExecutive Change · Shareholder VoteJun 18, 202510-Q10-QMay 1, 20258-KResults of OperationsMay 1, 2025DEFA14ADEFA14AApr 25, 2025DEF 14ADEF 14AApr 25, 202510-K10-KFeb 13, 20258-KResults of OperationsFeb 13, 20258-KExecutive ChangeFeb 13, 20258-KReg FD DisclosureJan 13, 20258-KReg FD DisclosureJan 6, 202510-Q10-QOct 31, 20248-KResults of OperationsOct 31, 202410-Q10-QAug 1, 20248-KResults of OperationsAug 1, 20248-KShareholder VoteJun 20, 20248-KMaterial Agreement · Company UpdateMay 28, 202410-Q10-QMay 2, 20248-KResults of OperationsMay 2, 2024DEFA14ADEFA14AApr 26, 2024DEF 14ADEF 14AApr 26, 202410-K10-KFeb 15, 20248-KResults of OperationsFeb 15, 20248-KReg FD DisclosureJan 8, 2024SC 13GSC 13GNov 9, 202310-Q10-QNov 2, 20238-KResults of OperationsNov 2, 202310-Q10-QAug 3, 20238-KResults of OperationsAug 3, 20238-KExecutive Change · Shareholder VoteJun 14, 20238-KExecutive ChangeMay 25, 202310-Q10-QMay 4, 20238-KResults of OperationsMay 4, 2023DEFA14ADEFA14AApr 26, 2023DEF 14ADEF 14AApr 26, 20238-KExecutive ChangeApr 19, 20238-KBylaw AmendmentMar 3, 202310-K10-KFeb 23, 20238-KResults of OperationsFeb 23, 2023SC 13GSC 13GFeb 14, 2023SC 13GSC 13GFeb 14, 20238-KReg FD DisclosureJan 9, 20238-KExecutive ChangeDec 16, 20228-KExecutive ChangeDec 6, 202210-Q10-QNov 3, 20228-KResults of OperationsNov 3, 20228-KMaterial Agreement · Company UpdateOct 27, 20228-KExecutive ChangeOct 7, 20228-KExecutive ChangeSep 19, 20228-KExecutive ChangeSep 7, 20228-KExecutive ChangeAug 15, 202210-Q10-QAug 4, 20228-KResults of OperationsAug 4, 20228-KExecutive ChangeJul 12, 20228-KShareholder VoteJun 22, 20228-KExecutive ChangeMay 26, 20228-KExecutive ChangeMay 18, 202210-Q10-QMay 5, 20228-KResults of OperationsMay 5, 2022DEFA14ADEFA14AApr 28, 2022DEF 14ADEF 14AApr 28, 20228-KExecutive ChangeApr 26, 202210-K10-KFeb 24, 20228-KResults of OperationsFeb 24, 2022SC 13GSC 13GFeb 14, 2022SC 13GSC 13GFeb 9, 2022SC 13GFILING AGIOS PHARMACEUTICALS, INC.Jan 19, 2022
Insider Activity
In the 90 days to Mar 5, 2026: 7 sold $2.2M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 5, 2026 | Viswanadhan KrishnanChief Corp Dev & Strategy | Sell | 2,959 | $27.80 | $82K |
| Mar 3, 2026 | Washburn Theodore James Jr.Principal Accounting Officer | Sell | 5,272 | $28.88 | $152K |
| Mar 2, 2026 | Goff BrianChief Executive Officer | Sell | 8,267 | $28.96 | $239K |
| Mar 2, 2026 | Goff BrianChief Executive Officer | Sell | 5,918 | $28.96 | $171K |
| Mar 2, 2026 | Goff BrianChief Executive Officer | Sell | 3,870 | $28.96 | $112K |
| Mar 2, 2026 | Gheuens SarahChief Medical Officer | Sell | 1,681 | $28.96 | $49K |
| Mar 2, 2026 | Burns James WilliamChief Legal Officer | Sell | 1,681 | $28.96 | $49K |
| Mar 2, 2026 | Jones CeciliaChief Financial Officer | Sell | 1,681 | $28.96 | $49K |
| Mar 2, 2026 | Milanova TsvetaChief Commercial Officer | Sell | 1,681 | $28.96 | $49K |
| Mar 2, 2026 | Jones CeciliaChief Financial Officer | Sell | 1,573 | $28.96 | $46K |
| Mar 2, 2026 | Gheuens SarahChief Medical Officer | Sell | 1,187 | $28.96 | $34K |
| Mar 2, 2026 | Burns James WilliamChief Legal Officer | Sell | 1,187 | $28.96 | $34K |
| Mar 2, 2026 | Jones CeciliaChief Financial Officer | Sell | 1,187 | $28.96 | $34K |
| Mar 2, 2026 | Milanova TsvetaChief Commercial Officer | Sell | 1,187 | $28.96 | $34K |
| Mar 2, 2026 | Burns James WilliamChief Legal Officer | Sell | 1,163 | $28.96 | $34K |
| Mar 2, 2026 | Washburn Theodore James Jr.Principal Accounting Officer | Sell | 798 | $28.96 | $23K |
| Mar 2, 2026 | Washburn Theodore James Jr.Principal Accounting Officer | Sell | 727 | $28.96 | $21K |
| Mar 2, 2026 | Washburn Theodore James Jr.Principal Accounting Officer | Sell | 698 | $28.96 | $20K |
| Mar 2, 2026 | Jones CeciliaChief Financial Officer | Sell | 594 | $28.96 | $17K |
| Jan 5, 2026 | Milanova TsvetaChief Commercial Officer | Sell | 2,872 | $27.02 | $78K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance